Zacks: Analysts Expect Medidata Solutions Inc (MDSO) Will Announce Earnings of $0.39 Per Share

Wall Street brokerages expect Medidata Solutions Inc (NASDAQ:MDSO) to announce earnings of $0.39 per share for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for Medidata Solutions’ earnings. The highest EPS estimate is $0.42 and the lowest is $0.36. Medidata Solutions posted earnings per share of $0.43 during the same quarter last year, which would suggest a negative year-over-year growth rate of 9.3%. The firm is expected to issue its next earnings report on Tuesday, July 23rd.

On average, analysts expect that Medidata Solutions will report full year earnings of $1.83 per share for the current fiscal year, with EPS estimates ranging from $1.77 to $1.88. For the next financial year, analysts anticipate that the firm will report earnings of $2.14 per share, with EPS estimates ranging from $2.00 to $2.27. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that follow Medidata Solutions.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.33. The company had revenue of $173.50 million for the quarter, compared to analyst estimates of $172.12 million. Medidata Solutions had a net margin of 7.99% and a return on equity of 9.28%. The business’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period last year, the business posted $0.40 EPS.

Several research firms have issued reports on MDSO. Wells Fargo & Co lowered shares of Medidata Solutions from an “outperform” rating to a “market perform” rating and set a $90.00 price target on the stock. in a research report on Tuesday, April 23rd. SunTrust Banks lowered shares of Medidata Solutions from a “buy” rating to a “hold” rating and set a $79.00 price target on the stock. in a research report on Wednesday, April 24th. William Blair began coverage on shares of Medidata Solutions in a research report on Monday, April 15th. They issued an “outperform” rating and a $74.93 price target on the stock. Zacks Investment Research lowered shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Monday, January 28th. Finally, Piper Jaffray Companies lifted their target price on shares of Medidata Solutions from $83.00 to $96.00 and gave the company an “overweight” rating in a research report on Tuesday, April 30th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $84.28.

In other Medidata Solutions news, EVP Daniel Patrick Shannon sold 19,725 shares of the business’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $75.17, for a total value of $1,482,728.25. Following the transaction, the executive vice president now directly owns 70,497 shares in the company, valued at $5,299,259.49. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Michael Pray sold 15,000 shares of the business’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $76.50, for a total transaction of $1,147,500.00. Following the completion of the transaction, the executive vice president now owns 77,134 shares in the company, valued at $5,900,751. The disclosure for this sale can be found here. 4.70% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in the business. Securian Asset Management Inc boosted its position in Medidata Solutions by 1.5% in the first quarter. Securian Asset Management Inc now owns 7,587 shares of the company’s stock valued at $556,000 after buying an additional 113 shares in the last quarter. Cigna Investments Inc. New raised its stake in shares of Medidata Solutions by 4.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,313 shares of the company’s stock worth $291,000 after acquiring an additional 178 shares during the last quarter. Stephens Inc. AR raised its stake in shares of Medidata Solutions by 8.7% in the fourth quarter. Stephens Inc. AR now owns 2,722 shares of the company’s stock worth $184,000 after acquiring an additional 218 shares during the last quarter. Front Row Advisors LLC raised its stake in shares of Medidata Solutions by 1.7% in the fourth quarter. Front Row Advisors LLC now owns 13,043 shares of the company’s stock worth $879,000 after acquiring an additional 220 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of Medidata Solutions by 2.2% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,971 shares of the company’s stock worth $804,000 after acquiring an additional 234 shares during the last quarter.

NASDAQ MDSO opened at $90.46 on Friday. The company has a current ratio of 2.57, a quick ratio of 2.71 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $5.63 billion, a price-to-earnings ratio of 94.23, a P/E/G ratio of 8.20 and a beta of 1.42. Medidata Solutions has a 52-week low of $60.10 and a 52-week high of $98.60.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Featured Story: Differences Between Momentum Investing and Long Term Investing

Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.